Ads
related to: axsm stock price chartdirexion.com has been visited by 10K+ users in the past month
Search results
Axsome (AXSM) Down on Public Offering of Common Stock
Zacks via Yahoo Finance· 11 months agoAxsome AXSM announced that it is floating a secondary issue of 3 million shares of its common stock...
Axsome (AXSM) Stock Falls Despite Q4 Earnings & Revenue Beat
Zacks via Yahoo Finance· 3 months agoAxsome Therapeutics, Inc. AXSM reported an adjusted loss of 73 cents per share for the fourth...
Axsome (AXSM) Focuses on Auvelity Launch to Fuel Its Growth
Zacks via Yahoo Finance· 1 year agoAxsome Therapeutics AXSM is progressing well with the launch of its first product, Auvelity...
Axsome (AXSM) Q4 Earnings Miss, Auvelity Records First Sales
Zacks via Yahoo Finance· 1 year agoAxsome Therapeutics, Inc. AXSM incurred an adjusted loss of $1.28 per share in the fourth quarter of...
Axsome (AXSM) Q2 Loss Narrower Than Expected, Revenues Miss
Zacks via Yahoo Finance· 2 years agoAxsome (AXSM) reports narrower-than-expected loss for the second quarter of 2022. The company...
Axsome (AXSM) Rides on New Drug Approval & Sunosi Buyout
Zacks via Yahoo Finance· 1 year agoAxsome (AXSM) receives FDA approval for Auvelity to treat major depressive disorder in August. The...
Axsome (AXSM) Stock Up 17% in Six Months: Here's Why
Zacks via Yahoo Finance· 1 year agoAxsome's (AXSM) shares have surged 17.2% in the past six months, owing to the launch of its first product, Auvelity, in October last year. Also, the...
Best Momentum Stocks to Buy for July 11th
Zacks via Yahoo Finance· 11 months agoHere are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 11th: Axsome Therapeutics, Inc. AXSM: This...
Institutional investors in Axsome Therapeutics, Inc. (NASDAQ:AXSM) see US$220m decrease in market...
Simply Wall St. via Yahoo Finance· 1 year agoTo get a sense of who is truly in control of Axsome Therapeutics, Inc. (NASDAQ:AXSM), it is...
7 Biotech Stocks to Buy for Q3
InvestorPlace via Yahoo Finance· 2 years agoBiotech stocks bottomed in mid-June and have seen some upward momentum since then. The recovery is in line with the broader market. But the industry has...
